发明名称 |
METHODS OF DIAGNOSIS AND RISK STRATIFICATION OF ADVERSE EVENTS IN POST MYOCARDIAL INFARCTION PATIENTS USING PRO-ADRENOMEDULLIN |
摘要 |
The invention provides methods for the diagnosis and risk stratification of adverse events in post-myocardial infarction patients by means of proADM, whereby a determination of the marker pro-adrenomedullin or partial sequence or a fragment thereof or contained in a marker combination (panel, cluster) is carried out on a post-myocardial infarction patient. The invention also provides a diagnostic device and a kit for the performance of the method of the method of the invention. |
申请公布号 |
US2015192595(A1) |
申请公布日期 |
2015.07.09 |
申请号 |
US201514664243 |
申请日期 |
2015.03.20 |
申请人 |
BRAHMS GMBH |
发明人 |
NG LEONG L.;BERGMANN ANDREAS;STRUCK JOACHIM;MORGENTHALER NILS;PAPASSOTIRIOU JANA |
分类号 |
G01N33/74 |
主分类号 |
G01N33/74 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for the in vitro diagnosis and/or risk stratification of an adverse event in post-myocardial infarction patients, comprising the step of determining the level of pro-adrenomedullin or partial peptides or fragments thereof from a post-myocardial infarction patient, wherein a significantly elevated level of pro-adrenomedullin correlates with a greater risk of an adverse event in said post-myocardial infarction patient. |
地址 |
HENNIGSDORF DE |